AI English summary of an SEC filing — figures as filed
HCA Healthcare HCAHCA Healthcare said revenues for Q3 2025 increased 9.6% to $19.161 billion from $17.487 billion in the prior-year quarter, and net income attributable to HCA Healthcare, Inc. totaled $1.643 billion, or $6.96 per diluted share.
Key points
AI summaryHCA Healthcare said revenues for Q3 2025 increased 9.6% to $19.161 billion from $17.487 billion in the prior-year quarter, and net income attributable to HCA Healthcare, Inc. totaled $1.643 billion, or $6.96 per diluted share.
The company cited a 6.1% increase in revenue per equivalent admission and a 3.2% increase in equivalent admissions as the primary drivers of consolidated revenue growth for Q3, and said the increase in state supplemental Medicaid revenue during the quarter had a favorable impact on revenue per equivalent admission.
HCA Healthcare said salaries and benefits as a percentage of revenues were 43.6% for Q3, compared to 45.0% in the prior-year quarter, supplies as a percentage of revenues were 14.5%, compared to 15.2%, and other operating expenses as a percentage of revenues were 21.8%, compared to 21.2%.
The company said cash provided by operating activities for the first 9 months of 2025 totaled $10.277 billion, compared to $7.955 billion in the prior-year period, and that it spent $7.509 billion on share repurchases and $517 million on dividends during the same period.
Key figures
Quarter ended September 30, 2025
- Revenue
- $19.2B
- Net income
- $1.6B
- EPS
- $6.96
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q3 2025 Revenues $19.161 billion, Net Income $1.643 billion
HCA Healthcare said revenues for Q3 2025 increased 9.6% to $19.161 billion from $17.487 billion in the prior-year quarter, and net income attributable to HCA Healthcare, Inc. totaled $1.643 billion, or $6.96 per diluted share.
Source · Based on the MD&A text of the filing
Revenue Growth Drivers: Revenue per Equivalent Admission and Equivalent Admissions
The company cited a 6.1% increase in revenue per equivalent admission and a 3.2% increase in equivalent admissions as the primary drivers of consolidated revenue growth for Q3, and said the increase in state supplemental Medicaid revenue during the quarter had a favorable impact on revenue per equivalent admission.
Source · Based on the MD&A text of the filing
Q3 Cost Ratios: Salaries and Benefits 43.6%, Supplies 14.5%
HCA Healthcare said salaries and benefits as a percentage of revenues were 43.6% for Q3, compared to 45.0% in the prior-year quarter, supplies as a percentage of revenues were 14.5%, compared to 15.2%, and other operating expenses as a percentage of revenues were 21.8%, compared to 21.2%.
Source · Based on the MD&A text of the filing
9-Month Operating Cash Flow $10.277 billion, Share Repurchases $7.509 billion
The company said cash provided by operating activities for the first 9 months of 2025 totaled $10.277 billion, compared to $7.955 billion in the prior-year period, and that it spent $7.509 billion on share repurchases and $517 million on dividends during the same period.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…